Dr Reddy’s Pounces On US Ciprodex Generic As Endo Stumbles
Follows Expiry Of Key Ciprodex Patents
Dr Reddy’s Laboratories has leapfrogged Endo by launching a generic version of of Bayer/Alcon’s Ciprodex (ciprofloxacin/dexamethasone) 0.3%/0.1% otic suspension, as the US firm was stung with a major rejection by the US FDA.
